Ask Our Expert: Insights into robust leachables strategies for biologic drugs

As biologic products become more complex, understanding the potential impact of leachables is increasingly important. Our Ask Our Expert article examines the scientific considerations for leachables assessment, analytical challenges associated with biologics, and strategies to support product development, regulatory submissions and lifecycle management.

Whether developing novel biologics, biosimilars or combination products, manufacturers face growing expectations to demonstrate a thorough understanding of potential leachables risks.

Complete the form now to access expert perspectives on emerging industry trends, risk-based decision making and practical considerations for developing robust leachables programmes that support both compliance and long-term product success.
Need help or have a question?
Glass vials on a production line representing pharmaceutical testing in Intertek Pharmaceutical Services India laboratory

Intertek Pharmaceutical Services India

Analytical Testing, Auditing and Process & Powder Safety Testing US FDA, MH-FDA, CDSCO, cGMP, GLP & NABL Certified Laboratory


Intertek Pharmceutical Services India
F-Wing, Tex Center, Chandivali Farm Road,
Chandivali, Andheri (E) Mumbai,
Maharashtra - 400072

T: +91-22-4245 0100
E: pharma-asia@intertek.com


Download Brochure

NEW:
Q&A: Leachables Assessments for Biologic Drugs

Guide: Pharmaceutical Packaging Assessment Following USP <1663> and USP <1664> Guidance

Guide: Evaluating the Durability and Integrity of Pharmaceutical Glass Packaging

Q&A: Takeaways from the Draft ICH Q3E Guidance